Mindray Medical International Limited, commonly known as Mindray, is a leading global provider of medical devices and solutions, headquartered in Shenzhen, China (CN). Founded in 1991, the company has established a strong presence in key operational regions, including North America, Europe, and Asia, making significant strides in the healthcare industry. Specialising in innovative medical technologies, Mindray focuses on areas such as patient monitoring, in-vitro diagnostics, and ultrasound imaging. Its core products are distinguished by their advanced features and user-friendly designs, catering to the diverse needs of healthcare professionals. With a commitment to quality and innovation, Mindray has achieved notable milestones, including numerous industry awards and recognitions, solidifying its position as a trusted partner in healthcare worldwide.
How does Mindray's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Mindray's score of 37 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Mindray reported total carbon emissions of approximately 53,279,800 kg CO2e for Scope 1, 68,619,750 kg CO2e for Scope 2, and 94,210,380 kg CO2e for Scope 3, resulting in a combined total of about 73,947,730 kg CO2e for Scope 1 and 2. This data is cascaded from its parent company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. For 2023, Mindray's emissions included approximately 7,207,560 kg CO2e for Scope 1 and 67,978,550 kg CO2e for Scope 2, leading to a total of about 75,186,110 kg CO2e for Scope 1 and 2. The company also disclosed Scope 3 emissions of approximately 2,769,470 kg CO2e, with significant contributions from upstream transportation and distribution. Mindray has set ambitious climate commitments, aiming for a 25% reduction in greenhouse gas (GHG) intensity for both Scope 1 and Scope 2 emissions by 2030, using 2021 as the baseline year. This commitment reflects the company's proactive approach to addressing climate change and reducing its carbon footprint.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mindray has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
